Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Histamine + mannitol + sodium chloride is a diagnostic combination used in provocation tests to evaluate airway and nasal hyperreactivity. Developed by Diater Laboratorio, this product is primarily utilized in the diagnosis and assessment of allergic rhinitis, allergic conjunctivitis, and controlled allergic asthma. The active component, histamine (administered as histamine dihydrochloride), acts as a potent agonist at histamine H1 receptors, inducing localized physiological responses such as bronchoconstriction, increased vascular permeability, and glandular secretion. These responses are measured to determine the threshold of sensitivity in patients. Mannitol is included in the lyophilized formulation as a stabilizing excipient, while 0.9% saline (sodium chloride) serves as the isotonic diluent for reconstitution and administration. This combination is a standardized tool for clinical allergy diagnostics rather than a therapeutic intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on histamine + mannitol + sodium chloride.